Vaxcyte Names Luis Jodar Chief Medical Officer

Company: Vaxcyte · Role: Chief Medical Officer · New CMO: Luis Jodar · Context: VAX-31 Phase III Readouts Approaching · Date: September 3, 2026 Summary Vaxcyte appointed Luis Jodar as chief medical officer as its 31-valent pneumococcal conjugate vaccine, VAX-31, approaches Phase III adult readouts…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Genentech / Astex | Breast Cancer Discovery Collaboration Amid gRED Restructuring
Sobi Licenses Lacutamab in $580 Million Deal
Neomorph – $100M Molecular Glue Financing
Dyne Seeks $300 Million After BLA Acceptance